Donna Welch

613 total citations
28 papers, 479 citations indexed

About

Donna Welch is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Allergy and Ophthalmology. According to data from OpenAlex, Donna Welch has authored 28 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 7 papers in Immunology and Allergy and 6 papers in Ophthalmology. Recurrent topics in Donna Welch's work include Ocular Surface and Contact Lens (17 papers), Allergic Rhinitis and Sensitization (7 papers) and Urticaria and Related Conditions (5 papers). Donna Welch is often cited by papers focused on Ocular Surface and Contact Lens (17 papers), Allergic Rhinitis and Sensitization (7 papers) and Urticaria and Related Conditions (5 papers). Donna Welch collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Donna Welch's co-authors include Mark B. Abelson, George W Ousler, Kathleen L. Krenzer, Katrina Wilcox Hagberg, P.J. Gomes, Thomas K. Mundorf, Paul J Gomes, Gail Torkildsen, John David Rodriguez and Alan A Rogers and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, Clinical & Experimental Allergy and Advances in experimental medicine and biology.

In The Last Decade

Donna Welch

25 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna Welch United States 9 410 208 185 132 103 28 479
Marisa Tesón Spain 9 445 1.1× 167 0.8× 152 0.8× 171 1.3× 106 1.0× 12 491
Ghislaine Rabut France 10 377 0.9× 188 0.9× 103 0.6× 175 1.3× 63 0.6× 17 431
Kenta Fujio Japan 15 431 1.1× 256 1.2× 200 1.1× 171 1.3× 129 1.3× 37 623
Bozorgmehr Pouyeh United States 5 336 0.8× 141 0.7× 124 0.7× 89 0.7× 118 1.1× 5 375
Priyanka Chhadva United States 10 387 0.9× 254 1.2× 96 0.5× 236 1.8× 121 1.2× 18 527
Yasutsugu Akasaki Japan 13 319 0.8× 202 1.0× 130 0.7× 127 1.0× 84 0.8× 33 468
Alberto López‐de la Rosa Spain 14 419 1.0× 250 1.2× 86 0.5× 274 2.1× 68 0.7× 39 491
Cecilia Chao United States 17 703 1.7× 347 1.7× 63 0.3× 438 3.3× 68 0.7× 38 775
Bernardo M. Cavalcanti United States 14 647 1.6× 365 1.8× 47 0.3× 390 3.0× 69 0.7× 34 768
K. Venkataraman United States 3 341 0.8× 155 0.7× 141 0.8× 90 0.7× 104 1.0× 5 353

Countries citing papers authored by Donna Welch

Since Specialization
Citations

This map shows the geographic impact of Donna Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Welch more than expected).

Fields of papers citing papers by Donna Welch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Welch. The network helps show where Donna Welch may publish in the future.

Co-authorship network of co-authors of Donna Welch

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Welch. A scholar is included among the top collaborators of Donna Welch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Welch. Donna Welch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodriguez, John David, et al.. (2020). An exploratory study to evaluate visual function endpoints in non-advanced age-related macular degeneration. BMC Ophthalmology. 20(1). 424–424. 5 indexed citations
2.
Barrett, Simon, Donna Welch, Mark G Rippon, & Alan A Rogers. (2020). Clinical evaluation of a superabsorbent polymer dressing in enabling self-care of wounds. British Journal of Community Nursing. 25(Sup6). S28–S36. 2 indexed citations
3.
Rodriguez, John David, et al.. (2019). Variable Contrast Flicker Tests in Early Dry Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 60(9). 1211–1211.
4.
Welch, Donna, et al.. (2014). Efficacy and Toxicity of Every 2 Weeks Docetaxel Regimen in Comparison With Weekly or Every 3 Weeks in Metastatic Prostate Cancer. American Journal of Clinical Oncology. 39(3). 266–270. 1 indexed citations
5.
Torkildsen, Gail, et al.. (2009). Evaluation of desloratadine on conjunctival allergen challenge‐induced ocular symptoms. Clinical & Experimental Allergy. 39(7). 1052–1059. 8 indexed citations
6.
Torkildsen, Gail, et al.. (2009). Evaluation of Functional Visual Performance Using the IVAD Method With Currently Marketed Artificial Tear Products. 50(13). 4649–4649. 1 indexed citations
7.
Walker, Pamela M., et al.. (2008). A Comparative Investigation of Spontaneous Blink Rates Across a Series of Tasks in Dry Eye and Control Patients. Investigative Ophthalmology & Visual Science. 49(13). 5317–5317. 1 indexed citations
8.
Ousler, George W, et al.. (2008). The Ocular Protection Index. Cornea. 27(5). 509–513. 100 indexed citations
9.
Kellerman, Donald J., George W Ousler, Donna Welch, et al.. (2004). Placebo–Controlled Evaluation of Diquafosol in a Controlled Adverse Environment(CAE). 45(13). 3892–3892. 1 indexed citations
10.
Gomes, P.J., et al.. (2004). Allergic Rhinoconjunctivitis is Mediated Primarily through Ocular Exposure to Allergen.. 45(13). 4849–4849.
11.
Ousler, George W, et al.. (2003). A Correlation Between Ocular Symptoms and Corneal Sensitivity in Dry Eye Patients: A Symptomatic Zone. Investigative Ophthalmology & Visual Science. 44(13). 2484–2484. 1 indexed citations
12.
Abelson, Mark B., et al.. (2003). Olopatadine Reduces Ocular Signs and Symptoms Associated With Allergic Conjunctivitis 16 Hours After Instillation. Investigative Ophthalmology & Visual Science. 44(13). 3736–3736. 3 indexed citations
13.
Welch, Donna, et al.. (2003). An Approach to a More Standardized Method of Evaluating Tear Film Break-Up Time. Investigative Ophthalmology & Visual Science. 44(13). 2485–2485. 1 indexed citations
14.
Mundorf, Thomas K., et al.. (2003). Evaluation of the comfort of Alphagan® P compared with Alphagan® in irritated eyes. Advances in Therapy. 20(6). 329–336. 24 indexed citations
15.
Welch, Donna, et al.. (2002). Factors that Influence the Inter-Blink Interval (IBI) as Measured by the Ocular Protection Index (OPI). Investigative Ophthalmology & Visual Science. 43(13). 56–56. 17 indexed citations
16.
Abelson, Mark B., et al.. (2002). Alternative Reference Values for Tear Film Break up Time in Normal and Dry Eye Populations. Advances in experimental medicine and biology. 506(Pt B). 1121–1125. 124 indexed citations
17.
Welch, Donna, et al.. (2002). Ocular Drying Associated with Oral Antihistamines (Loratadine) in the Normal Population-an Evaluation of Exaggerated Dose Effect. Advances in experimental medicine and biology. 506(Pt B). 1051–1055. 39 indexed citations
18.
Ousler, George W, et al.. (2002). Evaluation of the Time to “Natural Compensation” in Normal and Dry Eye Subject Populations During Exposure to a Controlled Adverse Environment. Advances in experimental medicine and biology. 506(Pt B). 1057–1063. 24 indexed citations
19.
20.
Welch, Donna, et al.. (2000). OCULAR DRYING ASSOCIATED WITH ORAL ANTIHISTAMINES (LORATADINE) IN THE NORMAL POPULATION - AN EVALUATION OF EXAGGERATED DOSE EFFECT.. Cornea. 19(Supplement 2). S135–S135. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marisa Tesón Breakdown of academic impact, for papers by Ghislaine Rabut Breakdown of academic impact, for papers by Kenta Fujio Breakdown of academic impact, for papers by Bozorgmehr Pouyeh Breakdown of academic impact, for papers by Priyanka Chhadva Breakdown of academic impact, for papers by Yasutsugu Akasaki Breakdown of academic impact, for papers by Alberto López‐de la Rosa Breakdown of academic impact, for papers by Cecilia Chao Breakdown of academic impact, for papers by Bernardo M. Cavalcanti Breakdown of academic impact, for papers by K. Venkataraman
Rankless by CCL
2026